Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial

Objectives: To study the effect of Vitamin D 3 supplementation on metabolic control in an obese type 2 diabetes Emirati population. Methods: This randomized double-blind clinical trial was conducted with 87 vitamin D-deficient obese, type 2 diabetic participants. The vitamin D-group ( n =45) and the...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of clinical nutrition Vol. 69; no. 6; pp. 707 - 711
Main Authors Sadiya, A, Ahmed, S M, Carlsson, M, Tesfa, Y, George, M, Ali, S H, Siddieg, H H, Abusnana, S
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.06.2015
Nature Publishing Group
Subjects
692/699
Adult
Alfacalcidol
Blood pressure
Body Mass Index
Calcifediol
Calcifediol - blood
Care and treatment
Cholecalciferol - administration & dosage
Cholecalciferol - adverse effects
Cholecalciferol - therapeutic use
Clinical Nutrition
Diabetes
Diabetes Mellitus, Type 2 - complications
Diabetes therapy
Dietary supplements
Dietary Supplements - adverse effects
Double-Blind Method
Epidemiology
Female
Glycated Hemoglobin A - analysis
Health aspects
Humans
Hyperparathyroidism, Secondary - epidemiology
Hyperparathyroidism, Secondary - etiology
Hyperparathyroidism, Secondary - prevention & control
Incidence
Internal Medicine
Lipids
Lost to Follow-Up
Male
Medicine
Medicine & Public Health
Metabolic Diseases
Metabolism
Methods
Middle Aged
Obesity
Obesity - complications
Original
original-article
Overweight persons
Parathyroid Hormone - blood
Patient Dropouts
Public Health
Thyroid
Type 2 diabetes
United Arab Emirates - epidemiology
Vitamin D
Vitamin D Deficiency - blood
Vitamin D Deficiency - complications
Vitamin D Deficiency - drug therapy
Vitamin D Deficiency - physiopathology
United Arab Emirates
Online AccessGet full text

Cover

Abstract Objectives: To study the effect of Vitamin D 3 supplementation on metabolic control in an obese type 2 diabetes Emirati population. Methods: This randomized double-blind clinical trial was conducted with 87 vitamin D-deficient obese, type 2 diabetic participants. The vitamin D-group ( n =45) and the placebo group ( n =42) were matched for gender, age, HbA1c and 25-hydroxy vitamin D (25(OH) D) at the baseline. The study was divided into two phases of 3 months each; in phase 1, the vitamin D-group received 6000 IU vitamin D 3 /day followed by 3000 IU vitamin D 3 /day in phase 2, whereas the placebo group ( n =42) received matching placebo. Results: After supplementation, serum 25(OH) D peaked in the vitamin D-group in phase 1 (77.2±30.1 nmol/l, P =0.003) followed by a decrease in the phase 2 (61.4±18.8 nmol/l, P =0.006), although this was higher compared with baseline. In the placebo group, no difference was observed in the serum 25(OH) D levels throughout the intervention. Relative to baseline serum, parathyroid hormone decreased 24% ( P =0.003) in the vitamin D-group in phase 2, but remained unchanged in the placebo group. No significant changes were observed in blood pressure, fasting blood glucose, HbA1c, C-peptide, creatinine, phosphorous, alkaline phosphatase, lipids, C-reactive protein or thyroid stimulating hormone concentrations compared with baseline in either group. Conclusions: Six months of vitamin D 3 supplementation to vitamin D-deficient obese type 2 diabetes patients in the UAE normalized the vitamin D status and reduced the incidence of eucalcemic parathyroid hormone elevation but showed no effect on the metabolic control.
AbstractList European Journal of Clinical Nutrition (2015) 69, 707-711; doi: 10.1038/ejcn.2014.251; published online 19 November 2014
OBJECTIVES: To study the effect of Vitamin [D.sub.3] supplementation on metabolic control in an obese type 2 diabetes Emirati population. METHODS: This randomized double-blind clinical trial was conducted with 87 vitamin D-deficient obese, type 2 diabetic participants. The vitamin D-group (n = 45) and the placebo group (n = 42) were matched for gender, age, HbA1c and 25- hydroxy vitamin D (25(OH) D) at the baseline. The study was divided into two phases of 3 months each;in phase 1, the vitamin D- group received 6000 IU vitamin [D.sub.3]/day followed by 3000 IU vitamin [D.sub.3]/day in phase 2, whereas the placebo group (n = 42) received matching placebo. RESULTS: After supplementation, serum 25(OH) D peaked in the vitamin D-group in phase 1 (77.2 ±30.1 nmol/l, P = 0.003) followed by a decrease in the phase 2 (61.4± 18.8 nmol/l, P = 0.006), although this was higher compared with baseline. In the placebo group, no difference was observed in the serum 25(OH) D levels throughout the intervention. Relative to baseline serum, parathyroid hormone decreased 24% (P = 0.003) in the vitamin D-group in phase 2, but remained unchanged in the placebo group. No significant changes were observed in blood pressure, fasting blood glucose, HbA1c, C-peptide, creatinine, phosphorous, alkaline phosphatase, lipids, C-reactive protein or thyroid stimulating hormone concentrations compared with baseline in either group. CONCLUSIONS: Six months of vitamin [D.sub.3] supplementation to vitamin D-deficient obese type 2 diabetes patients in the UAE normalized the vitamin D status and reduced the incidence of eucalcemic parathyroid hormone elevation but showed no effect on the metabolic control. European Journal of Clinical Nutrition (2015) 69, 707-711; doi: 10.1038/ejcn.2014.251; published online 19 November 2014
OBJECTIVES: To study the effect of Vitamin D3 supplementation on metabolic control in an obese type 2 diabetes Emirati population. METHODS: This randomized double-blind clinical trial was conducted with 87 vitamin D-decient obese, type 2 diabetic participants. The vitamin D-group (n = 45) and the placebo group (n = 42) were matched for gender, age, HbA1c and 25-hydroxy vitamin D (25(OH) D) at the baseline. The study was divided into two phases of 3 months each; in phase 1, the vitamin D-group received 6000 IU vitamin D3/day followed by 3000 IU vitamin D3/day in phase 2, whereas the placebo group (n = 42) received matching placebo. RESULTS: After supplementation, serum 25(OH) D peaked in the vitamin D-group in phase 1 (77.2 30.1 nmol/l, P = 0.003) followed by a decrease in the phase 2 (61.4 18.8 nmol/l, P = 0.006), although this was higher compared with baseline. In the placebo group, no difference was observed in the serum 25(OH) D levels throughout the intervention. Relative to baseline serum, parathyroid hormone decreased 24% (P = 0.003) in the vitamin D-group in phase 2, but remained unchanged in the placebo group. No signicant changes were observed in blood pressure, fasting blood glucose, HbA1c, C-peptide, creatinine, phosphorous, alkaline phosphatase, lipids, C-reactive protein or thyroid stimulating hormone concentrations compared with baseline in either group. CONCLUSIONS: Six months of vitamin D3 supplementation to vitamin D-decient obese type 2 diabetes patients in the UAE normalized the vitamin D status and reduced the incidence of eucalcemic parathyroid hormone elevation but showed no effect on the metabolic control.
Objectives: To study the effect of Vitamin D 3 supplementation on metabolic control in an obese type 2 diabetes Emirati population. Methods: This randomized double-blind clinical trial was conducted with 87 vitamin D-deficient obese, type 2 diabetic participants. The vitamin D-group ( n =45) and the placebo group ( n =42) were matched for gender, age, HbA1c and 25-hydroxy vitamin D (25(OH) D) at the baseline. The study was divided into two phases of 3 months each; in phase 1, the vitamin D-group received 6000 IU vitamin D 3 /day followed by 3000 IU vitamin D 3 /day in phase 2, whereas the placebo group ( n =42) received matching placebo. Results: After supplementation, serum 25(OH) D peaked in the vitamin D-group in phase 1 (77.2±30.1 nmol/l, P =0.003) followed by a decrease in the phase 2 (61.4±18.8 nmol/l, P =0.006), although this was higher compared with baseline. In the placebo group, no difference was observed in the serum 25(OH) D levels throughout the intervention. Relative to baseline serum, parathyroid hormone decreased 24% ( P =0.003) in the vitamin D-group in phase 2, but remained unchanged in the placebo group. No significant changes were observed in blood pressure, fasting blood glucose, HbA1c, C-peptide, creatinine, phosphorous, alkaline phosphatase, lipids, C-reactive protein or thyroid stimulating hormone concentrations compared with baseline in either group. Conclusions: Six months of vitamin D 3 supplementation to vitamin D-deficient obese type 2 diabetes patients in the UAE normalized the vitamin D status and reduced the incidence of eucalcemic parathyroid hormone elevation but showed no effect on the metabolic control.
To study the effect of Vitamin D3 supplementation on metabolic control in an obese type 2 diabetes Emirati population. This randomized double-blind clinical trial was conducted with 87 vitamin D-deficient obese, type 2 diabetic participants. The vitamin D-group (n=45) and the placebo group (n=42) were matched for gender, age, HbA1c and 25-hydroxy vitamin D (25(OH) D) at the baseline. The study was divided into two phases of 3 months each; in phase 1, the vitamin D-group received 6000 IU vitamin D3/day followed by 3000 IU vitamin D3/day in phase 2, whereas the placebo group (n=42) received matching placebo. After supplementation, serum 25(OH) D peaked in the vitamin D-group in phase 1 (77.2±30.1 nmol/l, P=0.003) followed by a decrease in the phase 2 (61.4±18.8 nmol/l, P=0.006), although this was higher compared with baseline. In the placebo group, no difference was observed in the serum 25(OH) D levels throughout the intervention. Relative to baseline serum, parathyroid hormone decreased 24% (P=0.003) in the vitamin D-group in phase 2, but remained unchanged in the placebo group. No significant changes were observed in blood pressure, fasting blood glucose, HbA1c, C-peptide, creatinine, phosphorous, alkaline phosphatase, lipids, C-reactive protein or thyroid stimulating hormone concentrations compared with baseline in either group. Six months of vitamin D3 supplementation to vitamin D-deficient obese type 2 diabetes patients in the UAE normalized the vitamin D status and reduced the incidence of eucalcemic parathyroid hormone elevation but showed no effect on the metabolic control.
To study the effect of Vitamin D3 supplementation on metabolic control in an obese type 2 diabetes Emirati population.OBJECTIVESTo study the effect of Vitamin D3 supplementation on metabolic control in an obese type 2 diabetes Emirati population.This randomized double-blind clinical trial was conducted with 87 vitamin D-deficient obese, type 2 diabetic participants. The vitamin D-group (n=45) and the placebo group (n=42) were matched for gender, age, HbA1c and 25-hydroxy vitamin D (25(OH) D) at the baseline. The study was divided into two phases of 3 months each; in phase 1, the vitamin D-group received 6000 IU vitamin D3/day followed by 3000 IU vitamin D3/day in phase 2, whereas the placebo group (n=42) received matching placebo.METHODSThis randomized double-blind clinical trial was conducted with 87 vitamin D-deficient obese, type 2 diabetic participants. The vitamin D-group (n=45) and the placebo group (n=42) were matched for gender, age, HbA1c and 25-hydroxy vitamin D (25(OH) D) at the baseline. The study was divided into two phases of 3 months each; in phase 1, the vitamin D-group received 6000 IU vitamin D3/day followed by 3000 IU vitamin D3/day in phase 2, whereas the placebo group (n=42) received matching placebo.After supplementation, serum 25(OH) D peaked in the vitamin D-group in phase 1 (77.2±30.1 nmol/l, P=0.003) followed by a decrease in the phase 2 (61.4±18.8 nmol/l, P=0.006), although this was higher compared with baseline. In the placebo group, no difference was observed in the serum 25(OH) D levels throughout the intervention. Relative to baseline serum, parathyroid hormone decreased 24% (P=0.003) in the vitamin D-group in phase 2, but remained unchanged in the placebo group. No significant changes were observed in blood pressure, fasting blood glucose, HbA1c, C-peptide, creatinine, phosphorous, alkaline phosphatase, lipids, C-reactive protein or thyroid stimulating hormone concentrations compared with baseline in either group.RESULTSAfter supplementation, serum 25(OH) D peaked in the vitamin D-group in phase 1 (77.2±30.1 nmol/l, P=0.003) followed by a decrease in the phase 2 (61.4±18.8 nmol/l, P=0.006), although this was higher compared with baseline. In the placebo group, no difference was observed in the serum 25(OH) D levels throughout the intervention. Relative to baseline serum, parathyroid hormone decreased 24% (P=0.003) in the vitamin D-group in phase 2, but remained unchanged in the placebo group. No significant changes were observed in blood pressure, fasting blood glucose, HbA1c, C-peptide, creatinine, phosphorous, alkaline phosphatase, lipids, C-reactive protein or thyroid stimulating hormone concentrations compared with baseline in either group.Six months of vitamin D3 supplementation to vitamin D-deficient obese type 2 diabetes patients in the UAE normalized the vitamin D status and reduced the incidence of eucalcemic parathyroid hormone elevation but showed no effect on the metabolic control.CONCLUSIONSSix months of vitamin D3 supplementation to vitamin D-deficient obese type 2 diabetes patients in the UAE normalized the vitamin D status and reduced the incidence of eucalcemic parathyroid hormone elevation but showed no effect on the metabolic control.
Objectives: To study the effect of Vitamin D sub(3) supplementation on metabolic control in an obese type 2 diabetes Emirati population. Methods: This randomized double-blind clinical trial was conducted with 87 vitamin D-deficient obese, type 2 diabetic participants. The vitamin D-group (n=45) and the placebo group (n=42) were matched for gender, age, HbA1c and 25-hydroxy vitamin D (25(OH) D) at the baseline. The study was divided into two phases of 3 months each; in phase 1, the vitamin D-group received 6000 IU vitamin D sub(3)/day followed by 3000 IU vitamin D sub(3)/day in phase 2, whereas the placebo group (n=42) received matching placebo. Results: After supplementation, serum 25(OH) D peaked in the vitamin D-group in phase 1 (77.2 plus or minus 30.1 nmol/l, P=0.003) followed by a decrease in the phase 2 (61.4 plus or minus 18.8 nmol/l, P=0.006), although this was higher compared with baseline. In the placebo group, no difference was observed in the serum 25(OH) D levels throughout the intervention. Relative to baseline serum, parathyroid hormone decreased 24% (P=0.003) in the vitamin D-group in phase 2, but remained unchanged in the placebo group. No significant changes were observed in blood pressure, fasting blood glucose, HbA1c, C-peptide, creatinine, phosphorous, alkaline phosphatase, lipids, C-reactive protein or thyroid stimulating hormone concentrations compared with baseline in either group. Conclusions: Six months of vitamin D sub(3) supplementation to vitamin D-deficient obese type 2 diabetes patients in the UAE normalized the vitamin D status and reduced the incidence of eucalcemic parathyroid hormone elevation but showed no effect on the metabolic control.
Audience Professional
Academic
Author Abusnana, S
Sadiya, A
Siddieg, H H
Tesfa, Y
Carlsson, M
George, M
Ahmed, S M
Ali, S H
Author_xml – sequence: 1
  givenname: A
  surname: Sadiya
  fullname: Sadiya, A
  email: amena.sadiya@rcdr.ae
  organization: Rashid Center for Diabetes and Research
– sequence: 2
  givenname: S M
  surname: Ahmed
  fullname: Ahmed, S M
  organization: Rashid Center for Diabetes and Research
– sequence: 3
  givenname: M
  surname: Carlsson
  fullname: Carlsson, M
  organization: Kalmar County Hospital, Kalmar, Sweden
– sequence: 4
  givenname: Y
  surname: Tesfa
  fullname: Tesfa, Y
  organization: Rashid Center for Diabetes and Research
– sequence: 5
  givenname: M
  surname: George
  fullname: George, M
  organization: Rashid Center for Diabetes and Research
– sequence: 6
  givenname: S H
  surname: Ali
  fullname: Ali, S H
  organization: Rashid Center for Diabetes and Research
– sequence: 7
  givenname: H H
  surname: Siddieg
  fullname: Siddieg, H H
  organization: Rashid Center for Diabetes and Research
– sequence: 8
  givenname: S
  surname: Abusnana
  fullname: Abusnana, S
  organization: Rashid Center for Diabetes and Research
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25406966$$D View this record in MEDLINE/PubMed
BookMark eNqFks9r2zAUx8XoWNNux12HYTB6mDNJtmR7h0Houh9Q2GXdVcjSc6IgS5lkD7rT_vTKJG2TkTF0kHj6fL-89_ieoRPnHSD0kuA5wUX9DtbKzSkm5Zwy8gTNSFnxnPESn6AZbliZFxhXp-gsxjVOVFXRZ-iUshLzhvMZ-vPDDLI3LvuYxXGzsdCDG-RgvMtS0bcQIRtuN5DRTBvZwgAxge0a1BAnYrHupXub3Syu3mcyC9Jp35vfoDPl3RC8temp_dhayFtrnJ5-0m2UtNkQjLTP0dNO2ggvdvc5uvl09f3yS3797fPXy8V1rnhTDDngrqQ1qKLralwTqHRBScMVbwmTDcOsYy2jkndMFoS1uim4Jh2niuJKlxQX5-jD1ncztj1olcYM0opNML0Mt8JLIw5_nFmJpf8lypLVdVMmg4udQfA_R4iD6E1UYK104McoSN1URcVTU_9Hec0xrzBtEvr6L3Ttx-DSJiaKkZpizB-ppbQgjOt8alFNpmJRkgo3RcNZovIj1BIcpHlSajqTygf8_AifjobeqKOCN3uCFUg7rKK34xSXeAi-2l_2w5bvc5eAYguo4GMM0AlltrFLLRgrCBZTusWUbjGlO0nJ44APqnvjf_G7AWPi3BLC3nKPCu4AkLUI8A
CitedBy_id crossref_primary_10_1097_HJH_0000000000001220
crossref_primary_10_3177_jnsv_68_1
crossref_primary_10_1024_0300_9831_a000673
crossref_primary_10_3945_ajcn_115_121848
crossref_primary_10_3390_nu15214575
crossref_primary_10_1007_s12272_022_01374_6
crossref_primary_10_1016_j_dsx_2018_11_008
crossref_primary_10_1159_000480711
crossref_primary_10_1093_nutrit_nuae226
crossref_primary_10_1016_j_clnu_2016_03_001
crossref_primary_10_3389_fendo_2022_920340
crossref_primary_10_3945_jn_117_254193
crossref_primary_10_1093_nutrit_nux077
crossref_primary_10_1097_MD_0000000000015284
crossref_primary_10_4162_nrp_2016_10_3_328
crossref_primary_10_1093_nutrit_nux059
crossref_primary_10_5812_ircmj_41718
crossref_primary_10_1002_dmrr_2969
crossref_primary_10_1093_nutrit_nux056
crossref_primary_10_1177_2042018815599874
crossref_primary_10_1093_nutrit_nuz037
crossref_primary_10_1136_bmjopen_2023_075607
crossref_primary_10_1530_EJE_16_0391
crossref_primary_10_1007_s00198_016_3837_7
crossref_primary_10_1177_03000605211033384
crossref_primary_10_1016_j_prostaglandins_2024_106938
crossref_primary_10_1016_j_arr_2018_05_004
crossref_primary_10_1016_j_metabol_2017_05_006
crossref_primary_10_3389_fcvm_2018_00087
crossref_primary_10_3390_nu16213651
crossref_primary_10_1186_s12902_015_0003_8
crossref_primary_10_1038_s41598_023_45846_1
crossref_primary_10_3389_fnut_2024_1419747
crossref_primary_10_3390_nu10030375
crossref_primary_10_1016_j_phrs_2021_105727
crossref_primary_10_3164_jcbn_20_165
crossref_primary_10_1097_MD_0000000000014970
crossref_primary_10_1111_dom_15941
crossref_primary_10_1155_2024_9960656
crossref_primary_10_3390_nu16081144
crossref_primary_10_1024_0300_9831_a000291
crossref_primary_10_1097_MD_0000000000037291
crossref_primary_10_3390_ijms20122891
crossref_primary_10_1002_biof_1496
crossref_primary_10_3803_EnM_2020_35_1_97
crossref_primary_10_1016_j_jsbmb_2022_106198
crossref_primary_10_1016_j_obmed_2021_100381
crossref_primary_10_1038_s41430_017_0062_1
crossref_primary_10_1186_s12902_022_01209_x
crossref_primary_10_5937_scriptamed51_28287
crossref_primary_10_3390_cells12010198
crossref_primary_10_1111_cea_12894
crossref_primary_10_1002_fsn3_2397
crossref_primary_10_1016_j_dsx_2020_03_019
crossref_primary_10_1016_j_jsbmb_2016_11_021
crossref_primary_10_1016_j_jsbmb_2018_02_003
crossref_primary_10_13005_bpj_2295
crossref_primary_10_3390_nu16223903
crossref_primary_10_1210_jc_2017_01024
crossref_primary_10_1016_j_clnu_2018_07_034
Cites_doi 10.1507/endocrj.47.383
10.1016/j.amjcard.2004.01.067
10.2337/dc12-s011
10.1016/j.diabres.2013.11.002
10.1038/ejcn.2011.118
10.2337/dc09-2321
10.1111/j.1365-2265.2011.04219.x
10.1186/1476-511X-11-11
10.1097/EDE.0b013e318176b8ad
10.1590/0004-2730000002535
10.2337/dc12-1204
10.1016/j.jsbmb.2004.03.115
10.1111/j.1464-5491.2012.03672.x
10.1155/2014/869307
10.2337/diacare.27.12.2813
10.1097/MCO.0b013e328359ef21
10.1007/s00125-010-1838-1
10.1111/j.1365-2796.2009.02181.x
10.1373/clinchem.2003.024802
10.3390/nu5030949
10.1159/000321527
10.4161/derm.3.4.16881
10.1093/ajcn/87.6.1952
10.1159/000412090
10.1007/s001250050685
10.1093/ajcn/72.3.690
10.1093/ajcn/79.5.820
10.1210/jc.2011-0385
10.2337/db08-0593
10.1111/j.1464-5491.2010.03092.x
10.1111/j.1464-5491.2007.02360.x
10.1093/ajcn/84.1.18
ContentType Journal Article
Copyright The Author(s) 2015
COPYRIGHT 2015 Nature Publishing Group
Copyright Nature Publishing Group Jun 2015
Copyright © 2015 Macmillan Publishers Limited 2015 Macmillan Publishers Limited
Copyright_xml – notice: The Author(s) 2015
– notice: COPYRIGHT 2015 Nature Publishing Group
– notice: Copyright Nature Publishing Group Jun 2015
– notice: Copyright © 2015 Macmillan Publishers Limited 2015 Macmillan Publishers Limited
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QP
7RV
7TK
7X2
7X7
7XB
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
8G5
ABUWG
AEUYN
AFKRA
AN0
ATCPS
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K9.
KB0
LK8
M0K
M0S
M1P
M2O
M7P
MBDVC
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
7TS
5PM
DOI 10.1038/ejcn.2014.251
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Calcium & Calcified Tissue Abstracts
Nursing & Allied Health Database
Neurosciences Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Journals
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
British Nursing Database
Agricultural & Environmental Science Collection
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Agricultural Science Database
ProQuest Health & Medical Collection
Medical Database
Research Library
Biological Science Database
Research Library (Corporate)
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
Physical Education Index
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
SciTech Premium Collection
ProQuest Central China
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Agricultural & Environmental Science Collection
ProQuest Research Library
ProQuest Public Health
ProQuest Central Basic
British Nursing Index with Full Text
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
ProQuest Central (Alumni)
MEDLINE - Academic
Physical Education Index
DatabaseTitleList

Agricultural Science Database

MEDLINE


MEDLINE - Academic
Physical Education Index
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
Anatomy & Physiology
Diet & Clinical Nutrition
DocumentTitleAlternate Vitamin D and metabolic control
EISSN 1476-5640
EndPage 711
ExternalDocumentID PMC4458894
3702896631
A417093965
25406966
10_1038_ejcn_2014_251
Genre Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
Feature
GeographicLocations United Arab Emirates
GeographicLocations_xml – name: United Arab Emirates
GroupedDBID ---
-ET
-Q-
.GJ
0R~
29G
2WC
36B
39C
4.4
406
53G
5GY
5RE
6PF
70F
7RV
7X2
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8G5
8R4
8R5
A8Z
AACDK
AAHBH
AAIKC
AAMNW
AANZL
AASML
AATNV
AAWTL
AAYZH
ABAKF
ABAWZ
ABBRH
ABCQX
ABDBE
ABDBF
ABFSG
ABJNI
ABLJU
ABOCM
ABRTQ
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMJI
ACPRK
ACRQY
ACSTC
ACUHS
ACZOJ
ADBBV
ADFRT
ADHUB
AEFQL
AEJRE
AEMSY
AENEX
AEUYN
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AI.
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AN0
APEBS
ATCPS
ATHPR
AXYYD
AYFIA
AZQEC
B0M
BAWUL
BBNVY
BENPR
BHPHI
BKEYQ
BKKNO
BKOMP
BNQBC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DNIVK
DPUIP
DU5
DWQXO
E.L
E3Z
EAD
EAP
EAS
EBC
EBD
EBLON
EBO
EBS
ECGQY
EE.
EHN
EIHBH
EIOEI
EJD
EMB
EMK
EMOBN
EPL
EPT
ESX
EX3
F5P
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
HZ~
IAG
IAO
ICU
IEA
IHR
IHT
IHW
INH
INR
IOF
ITC
IWAJR
JSO
JZLTJ
KQ8
LGEZI
LOTEE
M0K
M1P
M2O
M7P
NADUK
NAPCQ
NQJWS
NXXTH
O9-
OK1
OVD
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
Q~Q
RNS
RNT
RNTTT
ROL
RXW
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAE
TAOOD
TBHMF
TDRGL
TEORI
TH9
TR2
TSG
TUS
UKHRP
VH1
WH7
WOW
XOL
ZXP
~02
~8M
~KM
AAYXX
ACMFV
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
AEIIB
PMFND
3V.
7QP
7TK
7XB
8FK
K9.
LK8
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
7TS
5PM
ID FETCH-LOGICAL-c693t-e0f428ec3ff8081e7d32196c6b15a9505f5b52a6f5a315bd936d1f62c207d4203
IEDL.DBID 7X7
ISSN 0954-3007
1476-5640
IngestDate Thu Aug 21 18:34:08 EDT 2025
Fri Jul 11 01:54:05 EDT 2025
Thu Jul 10 23:52:00 EDT 2025
Sat Aug 16 02:51:15 EDT 2025
Tue Jun 17 21:34:03 EDT 2025
Thu Jun 12 23:39:06 EDT 2025
Tue Jun 10 20:37:15 EDT 2025
Thu May 22 20:07:42 EDT 2025
Mon Jul 21 05:38:06 EDT 2025
Tue Jul 01 03:15:20 EDT 2025
Thu Apr 24 22:57:49 EDT 2025
Mon Jul 21 06:06:59 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c693t-e0f428ec3ff8081e7d32196c6b15a9505f5b52a6f5a315bd936d1f62c207d4203
Notes SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://www.nature.com/articles/ejcn.2014.251
PMID 25406966
PQID 1685182006
PQPubID 33883
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4458894
proquest_miscellaneous_1897376196
proquest_miscellaneous_1686067029
proquest_journals_1685182006
gale_infotracmisc_A417093965
gale_infotracgeneralonefile_A417093965
gale_infotracacademiconefile_A417093965
gale_healthsolutions_A417093965
pubmed_primary_25406966
crossref_citationtrail_10_1038_ejcn_2014_251
crossref_primary_10_1038_ejcn_2014_251
springer_journals_10_1038_ejcn_2014_251
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-06-01
PublicationDateYYYYMMDD 2015-06-01
PublicationDate_xml – month: 06
  year: 2015
  text: 2015-06-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle European journal of clinical nutrition
PublicationTitleAbbrev Eur J Clin Nutr
PublicationTitleAlternate Eur J Clin Nutr
PublicationYear 2015
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Scragg (CR1) 2012; 15
Baynes, Boucher, Feskens, Kromhout (CR19) 1997; 40
Mehio Sibai, Nasreddine, Mokdad, Adra, Tabet, Hwalla (CR9) 2010; 57
Witham, Dove, Dryburgh, Sugden, Morris, Struthers (CR24) 2010; 53
Al Anouti, Thomas, Abdel-Wareth, Rajah, Grant, Haq (CR16) 2011; 3
Griz, Bandeira, Gabbay, Dib, Carvalho (CR13) 2014; 58
Albert, Glynn, Buring, Ridker (CR20) 2004; 93
Kayaniyil, Vieth, Retnakaran, Knight, Qi, Gerstein (CR4) 2010; 33
Holick, Binkley, Bischoff-Ferrari, Gordon, Hanley, Heaney (CR28) 2011; 96
Aloia, Patel, Dimaano, Li-Ng, Talwar, Mikhail (CR26) 2008; 87
Sugden, Davies, Witham, Morris, Struthers (CR22) 2008; 25
Knekt, Laaksonen, Mattila, Härkänen, Marniemi, Heliövaara (CR5) 2008; 19
Guariguata, Whiting, Hambleton, Beagley, Linnenkamp, Shaw (CR8) 2014; 103
Mitri, Muraru, Pittas (CR12) 2011; 65
Chiu, Chu, Go, Saad (CR25) 2004; 79
Maestro, Campión, Dávila, Calle (CR18) 2000; 47
Vanlint (CR7) 2013; 5
Scragg, Sowers, Bell (CR2) 2004; 27
Sadiya, Ahmed, Skaria, Abusnana (CR10) 2014; 2014
Hoelzel, Weykamp, Jeppsson, Miedema, Barr, Goodall (CR15) 2004; 50
CR29
Wang, Xia, Yang, Peng (CR30) 2012; 11
Jorde, Sneve, Torjesen, Figenschau (CR23) 2010; 267
Fitzpatrick (CR14) 1986; 15
Forouhi, Luan, Cooper, Boucher, Wareham (CR3) 2008; 57
Grimnes, Emaus, Joakimsen, Figenschau, Jenssen, Njølstad (CR6) 2010; 27
Bland, Markovic, Hills, Hughes, Chan, Squires (CR17) 2004; 89-90
(CR31) 2012; 35
George, Pearson, Witham (CR21) 2012; 29
Al-Daghri, Al-Attas, Alokail, Alkharfy, El-Kholie, Yousef (CR11) 2012; 76
Wortsman, Matsuoka, Chen, Lu, Holick (CR27) 2000; 72
Davidson, Duran, Lee, Friedman (CR32) 2013; 36
H Wang (BFejcn2014251_CR30) 2012; 11
A Mehio Sibai (BFejcn2014251_CR9) 2010; 57
NM Al-Daghri (BFejcn2014251_CR11) 2012; 76
J Wortsman (BFejcn2014251_CR27) 2000; 72
LH Griz (BFejcn2014251_CR13) 2014; 58
JF Aloia (BFejcn2014251_CR26) 2008; 87
R Jorde (BFejcn2014251_CR23) 2010; 267
NG Forouhi (BFejcn2014251_CR3) 2008; 57
MF Holick (BFejcn2014251_CR28) 2011; 96
TB Fitzpatrick (BFejcn2014251_CR14) 1986; 15
BFejcn2014251_CR29
G Grimnes (BFejcn2014251_CR6) 2010; 27
American Diabetes Association (BFejcn2014251_CR31) 2012; 35
R Scragg (BFejcn2014251_CR1) 2012; 15
R Scragg (BFejcn2014251_CR2) 2004; 27
P Knekt (BFejcn2014251_CR5) 2008; 19
L Guariguata (BFejcn2014251_CR8) 2014; 103
MA Albert (BFejcn2014251_CR20) 2004; 93
MD Witham (BFejcn2014251_CR24) 2010; 53
S Vanlint (BFejcn2014251_CR7) 2013; 5
J Mitri (BFejcn2014251_CR12) 2011; 65
S Kayaniyil (BFejcn2014251_CR4) 2010; 33
JA Sugden (BFejcn2014251_CR22) 2008; 25
MB Davidson (BFejcn2014251_CR32) 2013; 36
A Sadiya (BFejcn2014251_CR10) 2014; 2014
F Al Anouti (BFejcn2014251_CR16) 2011; 3
PS George (BFejcn2014251_CR21) 2012; 29
W Hoelzel (BFejcn2014251_CR15) 2004; 50
KC Chiu (BFejcn2014251_CR25) 2004; 79
KC Baynes (BFejcn2014251_CR19) 1997; 40
R Bland (BFejcn2014251_CR17) 2004; 89-90
B Maestro (BFejcn2014251_CR18) 2000; 47
23033239 - Diabetes Care. 2013 Feb;36(2):260-6
15225758 - J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):121-5
21088386 - Ann Nutr Metab. 2010;57(3-4):193-203
24630390 - Diabetes Res Clin Pract. 2014 Feb;103(2):137-49
16825677 - Am J Clin Nutr. 2006 Jul;84(1):18-28
22259650 - Dermatoendocrinol. 2011 Oct;3(4):235-9
21646368 - J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30
15113720 - Am J Clin Nutr. 2004 May;79(5):820-5
25371907 - J Diabetes Res. 2014;2014:869307
20596692 - Diabetologia. 2010 Oct;53(10):2112-9
20215450 - Diabetes Care. 2010 Jun;33(6):1379-81
24728158 - Arq Bras Endocrinol Metabol. 2014 Feb;58(1):1-8
22187469 - Diabetes Care. 2012 Jan;35 Suppl 1:S11-63
21906116 - Clin Endocrinol (Oxf). 2012 Mar;76(3):346-50
3512179 - Curr Probl Dermatol. 1986;15:25-38
14709644 - Clin Chem. 2004 Jan;50(1):166-74
9084975 - Diabetologia. 1997 Mar;40(3):344-7
11075718 - Endocr J. 2000 Aug;47(4):383-91
15135696 - Am J Cardiol. 2004 May 15;93(10):1238-42
20141565 - J Intern Med. 2010 May;267(5):462-72
18279409 - Diabet Med. 2008 Mar;25(3):320-5
10966885 - Am J Clin Nutr. 2000 Sep;72(3):690-3
18541590 - Am J Clin Nutr. 2008 Jun;87(6):1952-8
22433171 - Lipids Health Dis. 2012;11:42
23519290 - Nutrients. 2013 Mar;5(3):949-56
18496468 - Epidemiology. 2008 Sep;19(5):666-71
21731035 - Eur J Clin Nutr. 2011 Sep;65(9):1005-15
20854377 - Diabet Med. 2010 Oct;27(10):1107-15
18591391 - Diabetes. 2008 Oct;57(10):2619-25
22486204 - Diabet Med. 2012 Aug;29(8):e142-50
15562190 - Diabetes Care. 2004 Dec;27(12):2813-8
23037906 - Curr Opin Clin Nutr Metab Care. 2012 Nov;15(6):614-24
References_xml – volume: 47
  start-page: 383
  year: 2000
  end-page: 391
  ident: CR18
  article-title: Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells
  publication-title: Endocr J
  doi: 10.1507/endocrj.47.383
– volume: 93
  start-page: 1238
  year: 2004
  end-page: 1242
  ident: CR20
  article-title: C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study)
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2004.01.067
– volume: 35
  start-page: S11
  year: 2012
  end-page: S63
  ident: CR31
  article-title: Standards of medical care in diabetes–2012
  publication-title: Diabetes Care
  doi: 10.2337/dc12-s011
– volume: 103
  start-page: 137
  year: 2014
  end-page: 149
  ident: CR8
  article-title: Global estimates of diabetes prevalence for 2013 and projections for 2035
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2013.11.002
– volume: 65
  start-page: 1005
  year: 2011
  end-page: 1015
  ident: CR12
  article-title: Vitamin D and type 2 diabetes: a systematic review
  publication-title: Eur J Clin Nutr
  doi: 10.1038/ejcn.2011.118
– volume: 33
  start-page: 1379
  year: 2010
  end-page: 1381
  ident: CR4
  article-title: Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc09-2321
– volume: 76
  start-page: 346
  year: 2012
  end-page: 350
  ident: CR11
  article-title: Increased vitamin D supplementation recommended during summer season in the gulf region: a counterintuitive seasonal effect in vitamin D levels in adult, overweight and obese Middle Eastern residents
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2011.04219.x
– volume: 11
  start-page: 11
  year: 2012
  end-page: 42
  ident: CR30
  article-title: Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysys of randomized controlled trials
  publication-title: Lipids Health Dis
  doi: 10.1186/1476-511X-11-11
– volume: 19
  start-page: 666
  year: 2008
  end-page: 671
  ident: CR5
  article-title: Serum vitamin D and subsequent occurrence of type 2 diabetes
  publication-title: Epidemiology
  doi: 10.1097/EDE.0b013e318176b8ad
– volume: 58
  start-page: 1
  year: 2014
  end-page: 8
  ident: CR13
  article-title: Vitamin D and diabetes mellitus: an update 2013
  publication-title: Arq Bras Endocrinol Metabol
  doi: 10.1590/0004-2730000002535
– ident: CR29
– volume: 36
  start-page: 260
  year: 2013
  end-page: 266
  ident: CR32
  article-title: High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D
  publication-title: Diabetes Care
  doi: 10.2337/dc12-1204
– volume: 89-90
  start-page: 121
  year: 2004
  end-page: 125
  ident: CR17
  article-title: Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2004.03.115
– volume: 29
  start-page: e142
  year: 2012
  end-page: e150
  ident: CR21
  article-title: Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2012.03672.x
– volume: 2014
  start-page: 869307
  year: 2014
  ident: CR10
  article-title: Vitamin D status and its relationship with metabolic markers in persons with obesity and type 2 diabetes in the UAE: a cross-sectional study
  publication-title: J Diabetes Res
  doi: 10.1155/2014/869307
– volume: 27
  start-page: 2813
  year: 2004
  end-page: 2818
  ident: CR2
  article-title: Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey
  publication-title: Diabetes Care
  doi: 10.2337/diacare.27.12.2813
– volume: 15
  start-page: 614
  year: 2012
  end-page: 624
  ident: CR1
  article-title: Do we need to take calcium with vitamin D supplements to prevent falls, fractures, and death?
  publication-title: Curr Opin Clin Nutr Metab Care
  doi: 10.1097/MCO.0b013e328359ef21
– volume: 53
  start-page: 2112
  year: 2010
  end-page: 2119
  ident: CR24
  article-title: The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial
  publication-title: Diabetologia
  doi: 10.1007/s00125-010-1838-1
– volume: 267
  start-page: 462
  year: 2010
  end-page: 472
  ident: CR23
  article-title: No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.2009.02181.x
– volume: 50
  start-page: 166
  year: 2004
  end-page: 174
  ident: CR15
  article-title: IFCC Working Group on HbA1c Standardization. IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2003.024802
– volume: 5
  start-page: 949
  year: 2013
  end-page: 956
  ident: CR7
  article-title: Vitamin D and obesity
  publication-title: Nutrients
  doi: 10.3390/nu5030949
– volume: 57
  start-page: 193
  year: 2010
  end-page: 203
  ident: CR9
  article-title: Nutrition transition and cardiovascular disease risk factors in Middle East and North Africa countries: reviewing the evidence
  publication-title: Ann Nutr Metab
  doi: 10.1159/000321527
– volume: 3
  start-page: 235
  year: 2011
  end-page: 239
  ident: CR16
  article-title: Vitamin D deficiency and sun avoidance among university students at Abu Dhabi, United Arab Emirates
  publication-title: Dermatoendocrinol
  doi: 10.4161/derm.3.4.16881
– volume: 87
  start-page: 1952
  year: 2008
  end-page: 1958
  ident: CR26
  article-title: Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/87.6.1952
– volume: 15
  start-page: 25
  year: 1986
  end-page: 38
  ident: CR14
  article-title: Ultraviolet-induced pigmentary changes: benefits and hazards
  publication-title: Curr Probl Dermatol
  doi: 10.1159/000412090
– volume: 40
  start-page: 344
  year: 1997
  end-page: 347
  ident: CR19
  article-title: Vitamin D, glucose tolerance and insulinaemia in elderly men
  publication-title: Diabetologia
  doi: 10.1007/s001250050685
– volume: 72
  start-page: 690
  year: 2000
  end-page: 693
  ident: CR27
  article-title: Decreased bioavailability of vitamin D in obesity. Erratum in: Am J Clin Nutr. 2003; 77(5):1342
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/72.3.690
– volume: 79
  start-page: 820
  year: 2004
  end-page: 825
  ident: CR25
  article-title: Hypovitaminosis D is associated with insulin resistance and beta cell function
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/79.5.820
– volume: 96
  start-page: 1911
  year: 2011
  end-page: 1930
  ident: CR28
  article-title: Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-0385
– volume: 57
  start-page: 2619
  year: 2008
  end-page: 2625
  ident: CR3
  article-title: Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990–2000
  publication-title: Diabetes
  doi: 10.2337/db08-0593
– volume: 27
  start-page: 1107
  year: 2010
  end-page: 1115
  ident: CR6
  article-title: Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2010.03092.x
– volume: 25
  start-page: 320
  year: 2008
  end-page: 325
  ident: CR22
  article-title: Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2007.02360.x
– volume: 267
  start-page: 462
  year: 2010
  ident: BFejcn2014251_CR23
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.2009.02181.x
– ident: BFejcn2014251_CR29
  doi: 10.1093/ajcn/84.1.18
– volume: 57
  start-page: 2619
  year: 2008
  ident: BFejcn2014251_CR3
  publication-title: Diabetes
  doi: 10.2337/db08-0593
– volume: 87
  start-page: 1952
  year: 2008
  ident: BFejcn2014251_CR26
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/87.6.1952
– volume: 25
  start-page: 320
  year: 2008
  ident: BFejcn2014251_CR22
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2007.02360.x
– volume: 96
  start-page: 1911
  year: 2011
  ident: BFejcn2014251_CR28
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-0385
– volume: 47
  start-page: 383
  year: 2000
  ident: BFejcn2014251_CR18
  publication-title: Endocr J
  doi: 10.1507/endocrj.47.383
– volume: 89-90
  start-page: 121
  year: 2004
  ident: BFejcn2014251_CR17
  publication-title: J Steroid Biochem Mol Biol
  doi: 10.1016/j.jsbmb.2004.03.115
– volume: 5
  start-page: 949
  year: 2013
  ident: BFejcn2014251_CR7
  publication-title: Nutrients
  doi: 10.3390/nu5030949
– volume: 76
  start-page: 346
  year: 2012
  ident: BFejcn2014251_CR11
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2011.04219.x
– volume: 3
  start-page: 235
  year: 2011
  ident: BFejcn2014251_CR16
  publication-title: Dermatoendocrinol
  doi: 10.4161/derm.3.4.16881
– volume: 36
  start-page: 260
  year: 2013
  ident: BFejcn2014251_CR32
  publication-title: Diabetes Care
  doi: 10.2337/dc12-1204
– volume: 19
  start-page: 666
  year: 2008
  ident: BFejcn2014251_CR5
  publication-title: Epidemiology
  doi: 10.1097/EDE.0b013e318176b8ad
– volume: 27
  start-page: 2813
  year: 2004
  ident: BFejcn2014251_CR2
  publication-title: Diabetes Care
  doi: 10.2337/diacare.27.12.2813
– volume: 35
  start-page: S11
  year: 2012
  ident: BFejcn2014251_CR31
  publication-title: Diabetes Care
  doi: 10.2337/dc12-s011
– volume: 15
  start-page: 614
  year: 2012
  ident: BFejcn2014251_CR1
  publication-title: Curr Opin Clin Nutr Metab Care
  doi: 10.1097/MCO.0b013e328359ef21
– volume: 50
  start-page: 166
  year: 2004
  ident: BFejcn2014251_CR15
  publication-title: Clin Chem
  doi: 10.1373/clinchem.2003.024802
– volume: 72
  start-page: 690
  year: 2000
  ident: BFejcn2014251_CR27
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/72.3.690
– volume: 53
  start-page: 2112
  year: 2010
  ident: BFejcn2014251_CR24
  publication-title: Diabetologia
  doi: 10.1007/s00125-010-1838-1
– volume: 103
  start-page: 137
  year: 2014
  ident: BFejcn2014251_CR8
  publication-title: Diabetes Res Clin Pract
  doi: 10.1016/j.diabres.2013.11.002
– volume: 57
  start-page: 193
  year: 2010
  ident: BFejcn2014251_CR9
  publication-title: Ann Nutr Metab
  doi: 10.1159/000321527
– volume: 2014
  start-page: 869307
  year: 2014
  ident: BFejcn2014251_CR10
  publication-title: J Diabetes Res
  doi: 10.1155/2014/869307
– volume: 93
  start-page: 1238
  year: 2004
  ident: BFejcn2014251_CR20
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2004.01.067
– volume: 27
  start-page: 1107
  year: 2010
  ident: BFejcn2014251_CR6
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2010.03092.x
– volume: 15
  start-page: 25
  year: 1986
  ident: BFejcn2014251_CR14
  publication-title: Curr Probl Dermatol
  doi: 10.1159/000412090
– volume: 29
  start-page: e142
  year: 2012
  ident: BFejcn2014251_CR21
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2012.03672.x
– volume: 58
  start-page: 1
  year: 2014
  ident: BFejcn2014251_CR13
  publication-title: Arq Bras Endocrinol Metabol
  doi: 10.1590/0004-2730000002535
– volume: 40
  start-page: 344
  year: 1997
  ident: BFejcn2014251_CR19
  publication-title: Diabetologia
  doi: 10.1007/s001250050685
– volume: 79
  start-page: 820
  year: 2004
  ident: BFejcn2014251_CR25
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/79.5.820
– volume: 33
  start-page: 1379
  year: 2010
  ident: BFejcn2014251_CR4
  publication-title: Diabetes Care
  doi: 10.2337/dc09-2321
– volume: 11
  start-page: 11
  year: 2012
  ident: BFejcn2014251_CR30
  publication-title: Lipids Health Dis
  doi: 10.1186/1476-511X-11-11
– volume: 65
  start-page: 1005
  year: 2011
  ident: BFejcn2014251_CR12
  publication-title: Eur J Clin Nutr
  doi: 10.1038/ejcn.2011.118
– reference: 25371907 - J Diabetes Res. 2014;2014:869307
– reference: 18541590 - Am J Clin Nutr. 2008 Jun;87(6):1952-8
– reference: 14709644 - Clin Chem. 2004 Jan;50(1):166-74
– reference: 24630390 - Diabetes Res Clin Pract. 2014 Feb;103(2):137-49
– reference: 15562190 - Diabetes Care. 2004 Dec;27(12):2813-8
– reference: 20215450 - Diabetes Care. 2010 Jun;33(6):1379-81
– reference: 23037906 - Curr Opin Clin Nutr Metab Care. 2012 Nov;15(6):614-24
– reference: 15113720 - Am J Clin Nutr. 2004 May;79(5):820-5
– reference: 24728158 - Arq Bras Endocrinol Metabol. 2014 Feb;58(1):1-8
– reference: 23033239 - Diabetes Care. 2013 Feb;36(2):260-6
– reference: 10966885 - Am J Clin Nutr. 2000 Sep;72(3):690-3
– reference: 21088386 - Ann Nutr Metab. 2010;57(3-4):193-203
– reference: 23519290 - Nutrients. 2013 Mar;5(3):949-56
– reference: 11075718 - Endocr J. 2000 Aug;47(4):383-91
– reference: 22486204 - Diabet Med. 2012 Aug;29(8):e142-50
– reference: 20854377 - Diabet Med. 2010 Oct;27(10):1107-15
– reference: 18496468 - Epidemiology. 2008 Sep;19(5):666-71
– reference: 20596692 - Diabetologia. 2010 Oct;53(10):2112-9
– reference: 18279409 - Diabet Med. 2008 Mar;25(3):320-5
– reference: 21731035 - Eur J Clin Nutr. 2011 Sep;65(9):1005-15
– reference: 18591391 - Diabetes. 2008 Oct;57(10):2619-25
– reference: 15225758 - J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):121-5
– reference: 20141565 - J Intern Med. 2010 May;267(5):462-72
– reference: 21906116 - Clin Endocrinol (Oxf). 2012 Mar;76(3):346-50
– reference: 15135696 - Am J Cardiol. 2004 May 15;93(10):1238-42
– reference: 9084975 - Diabetologia. 1997 Mar;40(3):344-7
– reference: 21646368 - J Clin Endocrinol Metab. 2011 Jul;96(7):1911-30
– reference: 22433171 - Lipids Health Dis. 2012;11:42
– reference: 22259650 - Dermatoendocrinol. 2011 Oct;3(4):235-9
– reference: 3512179 - Curr Probl Dermatol. 1986;15:25-38
– reference: 22187469 - Diabetes Care. 2012 Jan;35 Suppl 1:S11-63
– reference: 16825677 - Am J Clin Nutr. 2006 Jul;84(1):18-28
SSID ssj0014772
Score 2.4014838
Snippet Objectives: To study the effect of Vitamin D 3 supplementation on metabolic control in an obese type 2 diabetes Emirati population. Methods: This randomized...
To study the effect of Vitamin D3 supplementation on metabolic control in an obese type 2 diabetes Emirati population. This randomized double-blind clinical...
OBJECTIVES: To study the effect of Vitamin [D.sub.3] supplementation on metabolic control in an obese type 2 diabetes Emirati population. METHODS: This...
European Journal of Clinical Nutrition (2015) 69, 707-711; doi: 10.1038/ejcn.2014.251; published online 19 November 2014
OBJECTIVES: To study the effect of Vitamin D3 supplementation on metabolic control in an obese type 2 diabetes Emirati population. METHODS: This randomized...
To study the effect of Vitamin D3 supplementation on metabolic control in an obese type 2 diabetes Emirati population.OBJECTIVESTo study the effect of Vitamin...
Objectives: To study the effect of Vitamin D sub(3) supplementation on metabolic control in an obese type 2 diabetes Emirati population. Methods: This...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 707
SubjectTerms 692/699
Adult
Alfacalcidol
Blood pressure
Body Mass Index
Calcifediol
Calcifediol - blood
Care and treatment
Cholecalciferol - administration & dosage
Cholecalciferol - adverse effects
Cholecalciferol - therapeutic use
Clinical Nutrition
Diabetes
Diabetes Mellitus, Type 2 - complications
Diabetes therapy
Dietary supplements
Dietary Supplements - adverse effects
Double-Blind Method
Epidemiology
Female
Glycated Hemoglobin A - analysis
Health aspects
Humans
Hyperparathyroidism, Secondary - epidemiology
Hyperparathyroidism, Secondary - etiology
Hyperparathyroidism, Secondary - prevention & control
Incidence
Internal Medicine
Lipids
Lost to Follow-Up
Male
Medicine
Medicine & Public Health
Metabolic Diseases
Metabolism
Methods
Middle Aged
Obesity
Obesity - complications
Original
original-article
Overweight persons
Parathyroid Hormone - blood
Patient Dropouts
Public Health
Thyroid
Type 2 diabetes
United Arab Emirates - epidemiology
Vitamin D
Vitamin D Deficiency - blood
Vitamin D Deficiency - complications
Vitamin D Deficiency - drug therapy
Vitamin D Deficiency - physiopathology
SummonAdditionalLinks – databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZQkRASQrDlEShgJLRcGkji2FlzW21bVUjtiUW9RX6lpNpNELs9wImfzozjRM2qIG7Z-LPs9WM8Gc98Q8i7JNe8ksLFTGsZ59ymsZKKx7lJpYafUnlT9tm5OF3mny_4RQhW3wS3yo7S0ovp3jvso7syyFaa5h8yDJi-i6ztuKAXYjFcGuSFz9UESgMa-5MiUGombDauPjqCdgXxjZNo10ty56rUn0Anj8jDoDrSedfZx-SOayZkfw7_o13_pFPqnTm9lXxCoqPabeFdoP1c0fOedX9C7p2F-_QJedBZ7WgXjLRPfn-tt2pdN_SIbjDdZ-dajtUovGy12ziKRlua0d5oC0CNtpwNIuZXa9Uc0uX8-BNVFI5B267rX87S4BG_gkfbQpsuhnbR-E770Ezq84c8IcuT4y-L0zjkaIiNkGwbu6SCDxhnWFVhDg9XWAYyUBihU64kqFcV1zxTouKKpVxbyYRNK5GZLClsniXsKdlr2sY9J1QZawRmamd2lmdOapYKmySqABnonFAROeynrTSBwBzzaKxKf5HOZiXOcomzXMIsR2Q6wL93zB1_A77BNVB2gafDji_neVokkknBI_LeI3DPQ4tGhdAF6DeyZ42Q0xHysuMOvw14MALCpjbj4n5BlkGobMpUgHo8QxtQRN4OxVgTHeUa1157jMDQq0z-AzOTOKYwTRF51q3xYYQyjqHQAkqK0eofAEhHPi5p6m-eljzHoGeZw2D1--RG128b-Bf_jXxJ7sMj71z0Dsje9se1ewXK4Fa_9iLgD0WpW4M
  priority: 102
  providerName: Springer Nature
Title Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial
URI https://link.springer.com/article/10.1038/ejcn.2014.251
https://www.ncbi.nlm.nih.gov/pubmed/25406966
https://www.proquest.com/docview/1685182006
https://www.proquest.com/docview/1686067029
https://www.proquest.com/docview/1897376196
https://pubmed.ncbi.nlm.nih.gov/PMC4458894
Volume 69
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9MwFLdgu3BBsPERGMNIqFwWFsexE3NBpes0IVEhRFFvkb8yOrXJoN0BTvzpvJePslRjlyrJ-1Vx_Oxn-_n59wh5HSVGFEr6kBujwkQ4FmqlRZhYpgzcKl27sj9N5Nk0-TgTs9bhtmrDKjubWBtqV1n0kR8zCXODDBfA7y9_hJg1CndX2xQad8kuUpdhSFc62yy4WJLWyZtgFoHe_yhtOTYjnh37C4vspyx5GwvWG5O2LfO1oWk7bHJr77Qekk4fkPvtXJIOG-U_JHd8uUf2hyWso5e_6IDW0Z2123yPBCdzv4ZnLQ_ogk46Gv598ufbfK2X85Ke0BUm-WwCylFG4WFl_MpTdNXSmHauWgAa9OCsEDG8WOryiE6H43dUUxj8XLWc__aOtnHwC7h01ZVZ-NAskJ4RJF0x6qwhj8j0dPx1dBa2mRlCKxVfhz4qYNniLS8KzNzhU8fB8kkrDRNawaSqEEbEWhZCcyaMU1w6VsjYxlHqkjjij8lOWZX-KaHaOisxPzt3WRJ7ZTiTLop0CpbPe6kDctTpJrctbTlmz1jk9fY5z3JUZY6qzEGVARls4JcNX8f_gC9R0Xlz3HTTz_NhwtJIcSVFQN7UCOzp8Ear2wMLUG7kzOohBz3kecMYfhPwoAeErmz74q7V5a0pWeX_Gn5AXm3E-E8Mjyt9dVVjJB64itUtmExhnYKaAvKkacibGooFHoCWIEl7TXwDQBLyvqScf6_JyBM86qwSqKyuM1wr-k0V_-z2j3xO7gFSNNF4B2Rn_fPKv4B539oc1p0bfrMROyS7H8aTz1_gbiRHfwGbxVnr
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdG9wAvCDY-AoMZCcrLwpI4dmokhArt1LGtQmhFewt27ECnNh20FRpP_EX8jdzli6Uae9tbmvslcX32-Xy-D0Kee6HmqRTWZVpLN-TGd5VU3A0TX2r4KVVuyj4aisEo_HDCT9bInyoWBt0qK5mYC2ozS9BGvusL0A06uAF-e_bdxapReLpaldAohsWBPf8JW7b5m_0e8PdFEOz1j98P3LKqgJsIyRau9VJQuW3C0hSrTtjIMJi1IhHa50qCQpByzQMlUq6Yz7WRTBg_FUESeJEJA4_Be2-Q9ZDBVqZF1t_1hx8_1ecWYZSXiwK9Bc8bvKjM6umxzq49TTDfqh--CrjfWAVX14ILi-Gqo-bKaW2-CO7dIbdL7ZV2i-F2l6zZbINsdjPYuU_PaZvm_qS5oX6DOL2xXcC9MvPohA6rxP-b5Pfn8UJNxxnt0TmWFS1c2JFG4eZM27mlaBymAa2MwwDUaDOaI6J7OlXZDh11-6-porDcmtl0_MsaWnreT-DSzJZ6Yl09wYSQQKmakdcpuUdG18K1-6SVzTL7kFCVmERgRXhmOmFgpWa-MJ6nIpC11grlkJ2KN3FSJkrHeh2TOD-wZ50YWRkjK2NgpUPaNfysyBDyP-A2MjouAlxryRJ3Qz_yJJOCO-RljkDZAl9MVBkiAe3GLF0NZLuB_FrkKL8MuNUAgvBImuRq1MWl8JrH_6aaQ57VZHwSHfIyO1vmGIEhXoG8AtOR2KfAJoc8KAZy3UMBx5BrAZSoMcRrAKY9b1Ky8bc8_XmIwdUyhM6qJsOFpl_W8Y-u_pPb5Obg-OgwPtwfHjwmt-ApXvgCbpHW4sfSPgGtc6GfllOdki_XLV3-Akekk-Y
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIiEuCFoehkIXCcKlJrbXu84iIRSRRi2FiANBvZl9GVIldiGJUDnxu_h1zPgR6qj01pvj-WxvdnZnZ2fnQcizINY8k8L5TGvpx9yGvpKK-7EJpYafUpWm7A8jcTCO3x3z4w3yp4mFQbfKRiaWgtoWBm3k3VCAbtDDDXA3q90iPg6Gb06_-1hBCk9am3Ia1RA5cmc_Yfs2f304AF4_j6Lh_qe3B35dYcA3QrKF74IM1G9nWJZhBQqXWAYzWBihQ64kKAcZ1zxSIuOKhVxbyYQNMxGZKEhsHAUM3nuNXE8YD3GOJcerzV4YJ2XhKNBg8OQhSOr8ngHrdd2JwcyrYfwy4mFrPVxfFc4ti-sum2vntuVyOLxNbtV6LO1XA-8O2XD5Ftnu57CHn53RDi09S0uT_RbxBhO3gHt1DtIpHTUlALbJ78-ThZpNcjqgcywwWjmzI43CzUK7uaNoJqYRbczEANRoPZojon8yU_keHff3X1FFYeG1xWzyy1la--BP4dIWSz11vp5iakigNM0oK5bcJeMr4dk9spkXuXtAqDLWCKwNz2wvjpzULBQ2CFQCUtc5oTyy1_AmNXXKdKzcMU3Lo3vWS5GVKbIyBVZ6pLOCn1a5Qv4H3EVGp1Wo60rGpP04TALJpOAeeVEiUMrAF42qgyWg3Zivq4XstJBfq2zlFwF3WkAQI6ZNbkZdWouxefpv0nnk6YqMT6JrXu6KZYkRGOwVyUswPYl9CmzyyP1qIK96KOIYfC2AkrSG-AqACdDblHzyrUyEHmOYtYyhs5rJcK7pF3X8w8v_5C65ATIlfX84OnpEbsJDvHIK3CGbix9L9xjUz4V-Us5zSr5ctWD5C4IQlrY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vitamin+D+supplementation+in+obese+type+2+diabetes+subjects+in+Ajman%2C+UAE%3A+a+randomized+controlled+double-blinded+clinical+trial&rft.jtitle=European+journal+of+clinical+nutrition&rft.au=Sadiya%2C+A&rft.au=Ahmed%2C+S+M&rft.au=Carlsson%2C+M&rft.au=Tesfa%2C+Y&rft.date=2015-06-01&rft.pub=Nature+Publishing+Group&rft.issn=0954-3007&rft.eissn=1476-5640&rft.volume=69&rft.issue=6&rft.spage=707&rft_id=info:doi/10.1038%2Fejcn.2014.251&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=3702896631
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0954-3007&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0954-3007&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0954-3007&client=summon